Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Placebo in the Treatment of Subjects Hospitalized With Community-Acquired Pneumonia

NCT00326287 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.

NCT NCT00326287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00326287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Placebo in the Treatment of Subjects Hospitalized With Community-Acquired Pneumonia
Lead sponsor
Basilea Pharmaceutica
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
July 31, 2007
Enrollment
638 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia